Capability readiness
How this wiki labels what is actually true about a capability, so that a reader can tell a public repository from an unverified prototype at a glance. This is the wiki’s main structural defence against a plausible-sounding but misleading capability list.
The problem
Capability maturity varies a lot — public repository versus “research prototype, code not verified.” Do not present a capability table as a single validated product suite; keep the per-row evidence pointer visible.
That instruction from the source material is a safeguard, and it governs Capability portfolio directly.
The readiness labels
| Label | Meaning | Example |
|---|---|---|
| Public code | An identifiable public repository exists | Exordium, LinMulT, BlinkLinMulT |
| Published | A peer-reviewed publication or formal record supports the claim | The ADOS-2 study, the AIRS paper |
| Research prototype | Demonstrated in a research context; maturity not verified | Skel3D (repository exists, models/instructions incomplete) |
| Historical | Documented past work, not claimed to be maintained or deployable today | LabelMovie, the AAC recommender |
| Opportunity | Discussed and plausible; no agreed plan, no commitment | Camera-based therapy monitoring, the Danish data route |
The five dimensions
Readiness in one dimension implies nothing about the others:
| Dimension | Question |
|---|---|
| Clinical validity | Does the measurement track what it claims to track? |
| Clinical utility | Does using it change decisions or outcomes? |
| Intellectual property | Who owns what, and on what terms? |
| Regulatory status | What is it permitted to be used for? |
| Commercial readiness | Could it be sold, supported and adopted? |
How this shows up in practice
- Speech Gap has strong IP and demonstrated sensitivity, and an untested prognostic application. Those coexist without contradiction.
- Argus Cognitive has an FDA-cleared product in cardiology and a separate autism product. Clearance for one is not clearance for the other.
- The Danish route is a genuine opportunity with no data access established.
Related pages
Capability portfolio · Clinical AI translation · Editorial safeguards · NIPG